Prothena Corporation’s Post

AL #amyloidosis is a #raredisease that can lead to severe organ dysfunction, particularly in the heart and kidneys. As the disease progresses, the financial and healthcare burden increases, highlighting the urgent need for continued research and efficient treatment options. Learn more: https://bit.ly/4kvVuH8 #AmyloidosisAwarenessMonth

Great company doing great work in the world of amyloidosis.

To view or add a comment, sign in

Explore topics